Bioengineering

  1. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase

    1. Souradeep Basu
    2. Tiffany Mak
    3. Rachel Ulferts
    4. Mary Wu
    5. Tom Deegan
    6. Ryo Fujisawa
    7. Kang Wei Tan
    8. Chew Theng Lim
    9. Clovis Basier
    10. Berta Canal
    11. Joseph F. Curran
    12. Lucy S. Drury
    13. Allison W. McClure
    14. Emma L. Roberts
    15. Florian Weissmann
    16. Theresa U. Zeisner
    17. Rupert Beale
    18. Victoria H. Cowling
    19. Michael Howell
    20. Karim Labib
    21. John F.X. Diffley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity

    1. Lisa R. Volpatti
    2. Rachel P. Wallace
    3. Shijie Cao
    4. Michal M. Raczy
    5. Ruyi Wang
    6. Laura T. Gray
    7. Aaron T. Alpar
    8. Priscilla S. Briquez
    9. Nikolaos Mitrousis
    10. Tiffany M. Marchell
    11. Maria Stella Sasso
    12. Mindy Nguyen
    13. Aslan Mansurov
    14. Erica Budina
    15. Ani Solanki
    16. Elyse A. Watkins
    17. Mathew R. Schnorenberg
    18. Andrew C. Tremain
    19. Joseph W. Reda
    20. Vlad Nicolaescu
    21. Kevin Furlong
    22. Steve Dvorkin
    23. Shann S. Yu
    24. Balaji Manicassamy
    25. James L. LaBelle
    26. Matthew V. Tirrell
    27. Glenn Randall
    28. Marcin Kwissa
    29. Melody A. Swartz
    30. Jeffrey A. Hubbell

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

    1. Shiho Tanaka
    2. Gard Nelson
    3. C. Anders Olson
    4. Oleksandr Buzko
    5. Wendy Higashide
    6. Annie Shin
    7. Marcos Gonzalez
    8. Justin Taft
    9. Roosheel Patel
    10. Sofija Buta
    11. Ashley Richardson
    12. Dusan Bogunovic
    13. Patricia Spilman
    14. Kayvan Niazi
    15. Shahrooz Rabizadeh
    16. Patrick Soon-Shiong

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2

    1. Yufei Xiang
    2. Sham Nambulli
    3. Zhengyun Xiao
    4. Heng Liu
    5. Zhe Sang
    6. W. Paul Duprex
    7. Dina Schneidman-Duhovny
    8. Cheng Zhang
    9. Yi Shi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Nanotraps for the containment and clearance of SARS-CoV-2

    1. Min Chen
    2. Jillian Rosenberg
    3. Xiaolei Cai
    4. Andy Chao Hsuan Lee
    5. Jiuyun Shi
    6. Mindy Nguyen
    7. Thirushan Wignakumar
    8. Vikranth Mirle
    9. Arianna Joy Edobor
    10. John Fung
    11. Jessica Scott Donington
    12. Kumaran Shanmugarajah
    13. Yiliang Lin
    14. Eugene Chang
    15. Glenn Randall
    16. Pablo Penaloza-MacMaster
    17. Bozhi Tian
    18. Maria Lucia Madariaga
    19. Jun Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Production of SARS-CoV-2 Virus-Like Particles in Insect Cells

    1. Youjun Mi
    2. Tao Xie
    3. Bingdong Zhu
    4. Jiying Tan
    5. Xuefeng Li
    6. Yanping Luo
    7. Fei Li
    8. Hongxia Niu
    9. Jiangyuan Han
    10. Wei Lv
    11. Juan Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response

    1. Qiu-Dong Su
    2. Ye-Ning Zou
    3. Yao Yi
    4. Li-Ping Shen
    5. Xiang-Zhong Ye
    6. Yang Zhang
    7. Hui Wang
    8. Hong Ke
    9. Jing-Dong Song
    10. Ke-Ping Hu
    11. Bo-Lin Cheng
    12. Feng Qiu
    13. Peng-Cheng Yu
    14. Wen-Ting Zhou
    15. Ran Zhao
    16. Lei Cao
    17. Gao-Feng Dong
    18. Sheng-Li Bi
    19. Gui-Zhen Wu
    20. George Fu Gao
    21. Jerry Zheng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Rapid generation of potent antibodies by autonomous hypermutation in yeast

    1. Alon Wellner
    2. Conor McMahon
    3. Morgan S. A. Gilman
    4. Jonathan R. Clements
    5. Sarah Clark
    6. Kianna M. Nguyen
    7. Ming H. Ho
    8. Vincent J. Hu
    9. Jung-Eun Shin
    10. Jared Feldman
    11. Blake M. Hauser
    12. Timothy M. Caradonna
    13. Laura M. Wingler
    14. Aaron G. Schmidt
    15. Debora S. Marks
    16. Jonathan Abraham
    17. Andrew C. Kruse
    18. Chang C. Liu

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2

    1. Emily C. Gale
    2. Abigail E. Powell
    3. Gillie A. Roth
    4. Emily L. Meany
    5. Jerry Yan
    6. Ben S. Ou
    7. Abigail K. Grosskopf
    8. Julia Adamska
    9. Vittoria C. T. M. Picece
    10. Andrea I. d'Aquino
    11. Bali Pulendran
    12. Peter S. Kim
    13. Eric A. Appel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery

    1. Alana Gerhardt
    2. Emily Voigt
    3. Michelle Archer
    4. Sierra Reed
    5. Elise Larson
    6. Neal Van Hoeven
    7. Ryan Kramer
    8. Christopher Fox
    9. Corey Casper

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 20 of 26 Next